Hypercontractile mutant of ventricular myosin essential light chain leads to disruption of sarcomeric structure and function and results in restrictive cardiomyopathy in mice.

Saved in:

Bibliographic Details
Title:	Hypercontractile mutant of ventricular myosin essential light chain leads to disruption of sarcomeric structure and function and results in restrictive cardiomyopathy in mice.
Authors:	Yuan CC; Molecular and Cellular Pharmacology, University of Miami Miller School of Medicine, Miami, FL 33136, USA., Kazmierczak K; Molecular and Cellular Pharmacology, University of Miami Miller School of Medicine, Miami, FL 33136, USA., Liang J; Molecular and Cellular Pharmacology, University of Miami Miller School of Medicine, Miami, FL 33136, USA., Kanashiro-Takeuchi R; Molecular and Cellular Pharmacology, University of Miami Miller School of Medicine, Miami, FL 33136, USA., Irving TC; Illinois Institute of Technology, Chicago, IL 60616, USA., Gomes AV; Department of Neurobiology, Physiology and Behavior, University of California, Davis, CA 95616, USA., Wang Y; Department of Biochemistry and Molecular Biology, Mayo Clinic Rochester, Rochester, MN 55905, USA., Burghardt TP; Department of Biochemistry and Molecular Biology, Mayo Clinic Rochester, Rochester, MN 55905, USA., Szczesna-Cordary D; Molecular and Cellular Pharmacology, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
Source:	Cardiovascular research [Cardiovasc Res] 2017 Aug 01; Vol. 113 (10), pp. 1124-1136.
Publication Type:	Journal Article
Journal Info:	Publisher: Oxford Journals Country of Publication: England NLM ID: 0077427 Publication Model: Print Cited Medium: Internet ISSN: 1755-3245 (Electronic) Linking ISSN: 00086363 NLM ISO Abbreviation: Cardiovasc Res Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1755-3245
DOI:	10.1093/cvr/cvx060